Aticaprant, a kappa opioid receptor antagonist, and the recovered ‘interest and pleasure’ in the concept of major depressive disorder
European Archives of Psychiatry and Clinical Neuroscience · 2025-09 · 275 (6) · 1593-1597
DOI: 10.1007/s00406-024-01851-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Archives of Psychiatry and Clinical Neuroscience, online erschienen am 06.07.2024. Verfasst von Koen Demyttenaere. Beteiligte Einrichtung: University Psychiatric Center KU Leuven, Leuven, Belgium. koen.demyttenaere@uzleuven.be. Hauptthemen laut MEDLINE: Major Depressive Disorder, Receptors, Opioid, kappa, Anhedonia, Benzeneacetamides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Psychiatric Center KU Leuven, Leuven, Belgium. koen.demyttenaere@uzleuven.be.
Zitieren
APA
Demyttenaere, K. (2025). Aticaprant, a kappa opioid receptor antagonist, and the recovered ‘interest and pleasure’ in the concept of major depressive disorder. European Archives of Psychiatry and Clinical Neuroscience, 275(6), 1593-1597. https://doi.org/10.1007/s00406-024-01851-7
Vancouver
Demyttenaere K. Aticaprant, a kappa opioid receptor antagonist, and the recovered ‘interest and pleasure’ in the concept of major depressive disorder. European Archives of Psychiatry and Clinical Neuroscience. 2025;275(6):1593-1597. doi:10.1007/s00406-024-01851-7
BibTeX
@article{Demyttenaere2025,
author = {Demyttenaere, Koen},
title = {Aticaprant, a kappa opioid receptor antagonist, and the recovered ‘interest and pleasure’ in the concept of major depressive disorder},
journal = {European Archives of Psychiatry and Clinical Neuroscience},
year = {2025},
volume = {275},
number = {6},
pages = {1593--1597},
doi = {10.1007/s00406-024-01851-7}
}
EUVIMED